Axsome Therapeutics Inc

19X

Company Profile

  • Business description

    Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

  • Contact

    One World Trade Center
    22nd Floor
    New YorkNY10007
    USA

    T: +1 212 332-3241

    E: [email protected]

    https://www.axsome.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    589

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,013.708.20-0.10%
CAC 407,285.8644.11-0.60%
DAX 4021,205.86105.16-0.49%
Dow JONES (US)38,170.41971.82-2.48%
FTSE 1008,275.660.060.00%
HKSE21,558.95163.810.77%
NASDAQ15,870.90415.55-2.55%
Nikkei 22534,224.3355.59-0.16%
NZX 50 Index11,836.69282.30-2.33%
S&P 5005,158.20124.50-2.36%
S&P/ASX 2007,816.702.40-0.03%
SSE Composite Index3,306.7815.350.47%

Market Movers